Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Resmed Inc (NY: RMD )

239.00 -3.56 (-1.47%)
Official Closing Price Updated: 7:00 PM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,131,070
Open 243.35
Bid (Size) 233.06 (1)
Ask (Size) 253.94 (1)
Prev. Close 242.56
Today's Range 238.74 - 246.00
52wk Range 132.24 - 255.18
Shares Outstanding 146,234,244
Dividend Yield 0.80%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expert Outlook: ResMed Through The Eyes Of 7 Analysts
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 21
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Sept. 16-20, 2024. 
Via Talk Markets

Performance

YTD
+39.13%
+39.13%
1 Month
-1.52%
-1.52%
3 Month
+24.86%
+24.86%
6 Month
+26.24%
+26.24%
1 Year
+59.28%
+59.28%

More News

Read More
Why ResMed Stock Tumbled by 5% Today
Via The Motley Fool
Stocks Edge Lower As Fed Rate Decision Looms, Treasury Yields Rise As Odds Improve For Smaller Cut: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
From ResMed Inc.
Via GlobeNewswire
Reasonable growth and debt and a high ROIC for RESMED INC (NYSE:RMD).
Via Chartmill
How Is The Market Feeling About ResMed?
Via Benzinga
Vaping Expected to Increase COPD Health and Economic Burden by 2050
From ResMed Inc.
Via GlobeNewswire
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
Via Benzinga
A Glimpse Into The Expert Outlook On ResMed Through 6 Analysts
Via Benzinga
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
Why Quality-Oriented Investors Should Consider NYSE:RMD.
Via Chartmill
NYSE:RMD may be ready to breakout.
Via Chartmill
Uncovering Dividend Opportunities with NYSE:RMD.
Via Chartmill
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,500 Today
Via Benzinga
$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
Via Benzinga
RxSight Stock Sees Relative Strength Rating Rise To 91
Via Investor's Business Daily
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
From ResMed Inc.
Via GlobeNewswire
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Via Benzinga
ResMed's Options Frenzy: What You Need to Know
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today
Via Benzinga
What 6 Analyst Ratings Have To Say About ResMed
Via Benzinga
ResMed Earnings Reflect Increased Demand For Sleep Devices, Performance Indicates Positive Dynamics, Opportunities
Via Benzinga
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.